The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population
International Journal of Epidemiology · 11.06.2025 · 54 (4)
DOI: 10.1093/ije/dyaf086 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Epidemiology, online erschienen am 18.06.2025. Verfasst von Charlotte Lanièce Delaunay und 30 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology Department, Epiconcept, Paris, France. Hauptthemen laut MEDLINE: COVID-19, Primary Health Care, COVID-19 Vaccines, Vaccine Efficacy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Centre for Disease Prevention and Control.
Abstract (Originalsprache)
Background
With SARS-CoV-2 self-tests, persons with acute respiratory infections (ARI) can know their COVID-19 status. This may alter their decision to consult a general practitioner (GP), potentially biasing COVID-19 vaccine effectiveness (VE) studies. We explore bias mechanisms, simulate magnitude, and verify control methods.
Methods
We used directed acyclic graphs (DAGs) to illustrate the bias mechanisms. Based on the European primary care VEBIS multicentre test-negative design (TND) study, we simulated populations with varying true VE (20%–60%), proportions of persons with ARI self-testing (10%–30%), effect of COVID-19 vaccination on self-testing (1.5–2.5), and effect of self-test result on GP consultation (0.5–2). We performed 5000 runs per scenario, estimating VE among those consulting a GP. We calculated bias as true VE minus mean simulated VE, unadjusted and adjusted for self-testing, using logistic regression.
Results
DAGs suggested collider stratification bias if vaccination had an effect on self-testing and if self-test results affected GP consultation. Bias was −12% to 18% at 20% true VE, with the most extreme associations and 30% self-testing. With 60% true VE and 10%–20% self-testing, bias was lower. Bias was higher (−18% to 45%) if both positive and negative self-test results affected GP consultation. Adjusting for self-testing removed the bias.
Conclusions
Self-testing may bias COVID-19 VE TND studies in primary care if self-testing is high, particularly with low VE. We recommend primary care TND VE studies collect self-testing information to eliminate potential bias. Observational studies are needed to understand the relationship between vaccination, self-testing, and GP consultation, in these studies’ source population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epidemiology Department, Epiconcept, Paris, France.
- Department of Communicable Diseases, National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.
- Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
- National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary.
- Epidemiology Department, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal.
- Department of Microbiology, The Public Health Agency of Sweden, Stockholm, Sweden.
ORCID-Profile: Charlotte Lanièce Delaunay, Gergő Túri, Ausenda Machado, Ivan Mlinarić, Raquel Guiomar, Jesús Castilla
Förderung
- European Centre for Disease Prevention and Control
Zitieren
APA
Lanièce Delaunay, C., Nunes, B., Monge, S., de Lange, M., Túri, G., Machado, A., Latorre-Margalef, N., Mlinarić, I., Lazar, M., Botella Rocamora, P., Erdwiens, A., Sève, N., Domegan, L., Martínez-Baz, I., Hooiveld, M., Oroszi, B., Guiomar, R., Sperk, M., Kurečić Filipović, S., …, & VEBIS Primary Care Vaccine Effectiveness Group (2025). The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population. International Journal of Epidemiology, 54(4). https://doi.org/10.1093/ije/dyaf086
Vancouver
Lanièce Delaunay C, Nunes B, Monge S, de Lange M, Túri G, Machado A, et al. The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population. International Journal of Epidemiology. 2025;54(4). doi:10.1093/ije/dyaf086
BibTeX
@article{LaniceDelaunay2025,
author = {Lanièce Delaunay, Charlotte and Nunes, Baltazar and Monge, Susana and de Lange, Marit and Túri, Gergő and Machado, Ausenda and Latorre-Margalef, Neus and Mlinarić, Ivan and Lazar, Mihaela and Botella Rocamora, Paloma and Erdwiens, Annika and Sève, Noémie and Domegan, Lisa and Martínez-Baz, Iván and Hooiveld, Mariëtte and Oroszi, Beatrix and Guiomar, Raquel and Sperk, Maike and Kurečić Filipović, Sanja and Pascu, Catalina and Linares Dopido, Juan Antonio and Dürrwald, Ralf and Rameix-Welti, Marie-Anne and McKenna, Adele and Castilla, Jesús and van Hagen, Cheyenne and Knol, Mirjam and Bacci, Sabrina and Kaczmarek, Marlena and Kissling, Esther and VEBIS Primary Care Vaccine Effectiveness Group, VEBIS Primary Care Vaccine Effectiveness Group},
title = {The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population},
journal = {International Journal of Epidemiology},
year = {2025},
volume = {54},
number = {4},
doi = {10.1093/ije/dyaf086}
}
EUVIMED